The Annals of Pharmacotherapy
Overview
The Annals of Pharmacotherapy is a peer-reviewed medical journal that focuses on the latest advancements in pharmacotherapy and medication management. It publishes original research articles, reviews, and case reports, providing healthcare professionals with valuable insights into drug therapy, adverse drug reactions, drug interactions, and therapeutic approaches. This journal serves as a reliable resource for pharmacists, physicians, and other healthcare providers seeking evidence-based information to optimize patient care and improve medication outcomes.
Details
Details
Abbr.
Ann Pharmacother
Start
1992
End
Continuing
Frequency
Monthly (except July/Aug. combined)
p-ISSN
1060-0280
e-ISSN
1542-6270
Country
United States
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 2180
122
SJR / Ranks: 5487
779
CiteScore / Ranks: 4260
5.60
JIF / Ranks: 3624
2.9
Recent Articles
1.
Kido K, Shimizu M, Shiga T, Hashiguchi M
Ann Pharmacother
. 2025 Mar;
:10600280251325250.
PMID: 40088126
No abstract available.
2.
Delp H, Olson M, Owen E, McEvoy C, Gill E
Ann Pharmacother
. 2025 Mar;
:10600280251319757.
PMID: 40088102
Background: Serotonin reuptake inhibitor (SRI) antidepressants have known antiplatelet properties. Patients with hematologic malignancies (HMs) are at an increased risk of bleeding complications due to their malignancy and treatment-induced thrombocytopenia....
3.
Nowak K, Lupina K, Romac A, Kalisz A, Ilkiewicz L, Janczura J
Ann Pharmacother
. 2025 Mar;
:10600280251322002.
PMID: 40072011
Objective: To summarize the current knowledge on the therapeutic potential of GLP-1 receptor agonists in managing metabolic associated steatotic liver disease (MASLD). Data Sources: A literature review was conducted using...
4.
Ooi H, Asai Y, Kondo Y, Tashiro T, Zakoji N, Aoki M, et al.
Ann Pharmacother
. 2025 Mar;
:10600280251319519.
PMID: 40071844
Background: Although therapeutic drug monitoring (TDM) maintains serum teicoplanin (TEIC) concentration between 15 and 30 μg/mL, TEIC-induced liver injury may still occur. The albumin-bilirubin (ALBI)-fibrosis-4 (FIB-4) score may be useful...
5.
Khoury A, Powell J
Ann Pharmacother
. 2025 Mar;
:10600280251320069.
PMID: 40071821
Objective: To review the published data including the pharmacology, efficacy, and safety of seladelpar, a peroxisome proliferator-activated receptor delta (PPARδ) agonist leading to the Food and Drug Administration (FDA) accelerated...
6.
Ahmadi F, Chalabianloo N, McArthur E, Omrani M, Abdullah S, Garcia-Bournissen F, et al.
Ann Pharmacother
. 2025 Feb;
:10600280251320690.
PMID: 40012193
Background: The US Food and Drug Administration (FDA) has raised concerns about a potential link between trimethoprim/sulfamethoxazole (TMP-SMX) and an increased risk of acute respiratory failure/acute respiratory distress syndrome (ARF/ARDS)...
7.
Kovalenko K, Bubalo J, Saultz J, Malla P
Ann Pharmacother
. 2025 Feb;
:10600280251321324.
PMID: 40012142
Background: Despite prophylaxis, acute graft-versus-host disease (aGVHD) occurs in up to 40% to 60% of patients undergoing an allogeneic hematopoietic stem cell transplantation (alloHSCT). Tacrolimus remains a common GVHD prophylactic...
8.
Donkor K, Jang H, Selim J, Ioffe Y, Hong L
Ann Pharmacother
. 2025 Feb;
:10600280251320067.
PMID: 40012138
Background: Hypersensitivity reactions (HSRs) are often encountered in patients receiving paclitaxel infusions. The conventional method, comprising dexamethasone 20 mg (Dex20) taken 12 and 6 hours before paclitaxel plus histamine (H)1...
9.
Xu B, Yang M, Li S, Kang B, Zhou J
Ann Pharmacother
. 2025 Feb;
:10600280251317495.
PMID: 39987514
Background: Adults with type 2 diabetes mellitus (T2DM) are at an increased risk for certain brain or psychiatric disorders, as are those with or without chronic kidney disease or heart...
10.
Martins S, Jesus A, Andrade R, Rocha M, Martin-Suarez A
Ann Pharmacother
. 2025 Feb;
:10600280251316542.
PMID: 39987509
Background: Radiopharmaceuticals are essential in the field of nuclear medicine, but like any other medicinal product, radiopharmaceuticals can potentially cause adverse reactions in patients. Objective: To describe the adverse reactions...